Researchers look to fungus to shed light on cancer

February 11, 2020

TALLAHASSEE, Fla. -- A fungus that attacks almond and peach trees may be key to identifying new drug targets for cancer therapy.

A team of Florida State University researchers from the Department of Chemistry and Biochemistry found that a natural product from the fungus Fusicoccum amygdali stabilizes a family of proteins in the cell that mediate important signaling pathways involved in the pathology of cancer and neurological diseases.

Their work is published in the journal ACS Chemical Biology.

Assistant Professor James Frederich and Professor Brian Miller found that fusicoccin -- a product derived from the fungus -- binds to and stabilizes protein complexes formed between 14-3-3 adaptor proteins and a subset of their client interaction partners. The 14-3-3 proteins are essentially major intersections in cells for signaling and regulatory operations. When their functions go awry, a disease is often present.

"Our goal in this study was to take one of the most intractable signaling networks in cell biology and develop a way to study it," Frederich said. "Our work draws inspiration from a structurally complex natural product, which we used as a tool to identify new targets for cancer cell biology."

Through this process, Frederich, Miller and their students identified 119 protein-protein interactions (PPIs) that can serve as targets for fusicoccin in humans. Several of these PPIs are important in cancer and other diseases. The research team has already narrowed that list down to 14 PPI targets that they find particularly promising.

"Our discovery of several new putative biological targets, which could clarify the mechanism of action of this natural product, is a major step forward," Miller said. "Identifying these new targets is very exciting, as is the potential to inform the design of fusicoccin derivatives with tailored activities."

The work is an ongoing collaboration between Frederich and Miller, who merged their areas of expertise in organic chemistry and biochemistry to explore the potential of fusicoccin.

"The unique combination of experiments and bioinformatics presented in this work lies squarely at the interface between chemistry and biology," Miller said. "We are hopeful that these types of chemical biology collaborations can be expanded."
-end-
This work is funded by the National Institutes of Health and supported by the Pfeiffer Endowed Professorship for Cancer Research. FSU graduate students Ananya Sengupta and Josue Liriano also contributed to this research.

Florida State University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.